STOCK TITAN

Arcutis Biotherapeutics (ARQT) director trust reports 187,500 shares on Form 3

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Arcutis Biotherapeutics, Inc. director Christopher Peetz filed an initial ownership report listing 187,500 shares of common stock held indirectly through The Peetz Family Trust dated February 15, 2017. He is a trustee and disclaims beneficial ownership beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Peetz Christopher
Role Director
Type Security Shares Price Value
holding Common Stock F1 -- -- --
Holdings After Transaction: Common Stock — 187,500 shares (Indirect, By The Peetz Family Trust)
Footnotes (1)
  1. F1. Shares held by The Peetz Family Trust dated February 15, 2017, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
Indirectly held common shares 187,500 shares Common stock reported for The Peetz Family Trust as of 2026-07-15
Trust date February 15, 2017 Date of The Peetz Family Trust holding Arcutis shares
beneficial ownership regulatory
"shall not be deemed an admission of beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
Section 16 regulatory
"beneficial ownership of such securities for purposes of Section 16 or for any other purposes"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
trustee other
"Shares held by The Peetz Family Trust ... of which the Reporting Person is a trustee"
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider ownership did Arcutis Biotherapeutics (ARQT) report for Christopher Peetz?

Arcutis reported that Christopher Peetz has an indirect interest in 187,500 shares of common stock, held through The Peetz Family Trust. This is an initial ownership report on Form 3, not a new purchase or sale of ARQT shares.

How are Christopher Peetz's ARQT shares held according to this Form 3?

The Form 3 states that 187,500 ARQT shares are held by The Peetz Family Trust, dated February 15, 2017. Christopher Peetz is a trustee, so the shares are reported as indirect ownership rather than being held directly in his own name.

Does Christopher Peetz claim full beneficial ownership of his ARQT holdings?

No. The footnote explains he disclaims beneficial ownership of the trust-held ARQT shares except for his pecuniary interest. It further states that including these securities should not be viewed as admitting beneficial ownership for Section 16 or any other purposes.

What is the significance of The Peetz Family Trust in the ARQT Form 3 filing?

The Peetz Family Trust, dated February 15, 2017, is the entity that actually holds the 187,500 ARQT shares. Christopher Peetz reports the position because he is a trustee, but he limits his claimed interest to whatever economic stake he personally has.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Peetz Christopher

(Last)(First)(Middle)
C/O ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, SUITE 300

(Street)
WESTLAKE VILLAGE CALIFORNIA 91361

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/15/2026
3. Issuer Name and Ticker or Trading Symbol
Arcutis Biotherapeutics, Inc. [ ARQT ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock187,500IBy The Peetz Family Trust(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares held by The Peetz Family Trust dated February 15, 2017, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
Remarks:
Exhibit list: EX-24 - Power of Attorney.
/s/Latha Vairavan, as Attorney-in-Fact for Christopher Peetz07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)